The laboratory diagnosis of Pseudomonas aeruginosa that produce metallo-β-lactamases in a Dutch tertiary care centre
Authors:
- 28 March 2011
- journal article
- Published by Taylor & Francis in Scandinavian Journal of Infectious Diseases
- Vol. 43 (8) , 596-602
Abstract
Background: The laboratory detection of Pseudomonas aeruginosa that produce metallo-β-lactamases (MBLs) is not well defined in regions with a low prevalence of these enzymes. We report a study that developed ethylenediaminetetraacetic acid (EDTA) disk screen tests using doripenem, imipenem and meropenem and investigated the prevalence of these enzymes among clinical isolates of imipenem-resistant P. aeruginosa in Rotterdam during 2008–2009. Methods: Using strains with well-characterized β-lactamases and the Clinical and Laboratory Standards Institute (CLSI) disk methodology similar to extended-spectrum β-lactamase (ESBL) detection, inhibition zone diameters were determined in tests with doripenem, imipenem, and meropenem, alone and in combination with 370 μg of EDTA. These tests were compared with the MBL E-test. A positive test was a ≥5 mm increase in zone diameter in the presence of EDTA. Results: The imipenem EDTA disk screen test showed a sensitivity of 100% and a specificity of 90% in 96 recent clinical isolates. Imipenem in combination with doripenem performed better than imipenem alone, meropenem, and the MBL E-test (sensitivity of 100%; specificity of 95%). The majority of clinical isolates were isolated from patient respiratory specimens. Of the 96 imipenem-resistant P. aeruginosa isolated, 35 (36%) were positive for blaVIM genes. Conclusions: The EDTA imipenem/doripenem disk test showed accurate and reproducible results with excellent sensitivity and specificity. It is simple to perform and interpret and can be easily introduced into the workflow of a clinical laboratory to screen for MBLs in imipenem-resistant P. aeruginosa. Due to its high specificity the test is also suitable for regions with a low prevalence of these enzymes.Keywords
This publication has 28 references indexed in Scilit:
- Detection of AmpC β-lactamases in Escherichia coli, Klebsiella spp., Salmonella spp. and Proteus mirabilis in a regional clinical microbiology laboratoryClinical Microbiology and Infection, 2010
- Susceptibility of Pseudomonas aeruginosa clinical isolates in Japan to doripenem and other antipseudomonal agentsInternational Journal of Antimicrobial Agents, 2009
- Controlling for false positives: interpreting MBL Etest and MBL combined disc test for the detection of metallo- -lactamasesJournal of Antimicrobial Chemotherapy, 2009
- Metallo-β-Lactamase Detection: Comparative Evaluation of Double-Disk Synergy versus Combined Disk Tests for IMP-, GIM-, SIM-, SPM-, or VIM-Producing IsolatesJournal of Clinical Microbiology, 2008
- Metallo beta lactamases inPseudomonas aeruginosaand Acinetobacter speciesExpert Opinion on Investigational Drugs, 2008
- Nosocomial spread of Pseudomonas aeruginosa producing the metallo-β-lactamase VIM-2 in a Spanish hospital: clinical and epidemiological implicationsClinical Microbiology and Infection, 2007
- Prospective evaluation of imipenem/EDTA combined disc and Etest for detection of metallo-β-lactamase-producing Pseudomonas aeruginosaJournal of Antimicrobial Chemotherapy, 2007
- Identification of Extended-Spectrum, AmpC, and Carbapenem- Hydrolyzing β-Lactamases in Escherichia coli and Klebsiella pneumoniae by Disk TestsJournal of Clinical Microbiology, 2006
- Population‐Based Epidemiological Study of Infections Caused by Carbapenem‐ResistantPseudomonas aeruginosain the Calgary Health Region: Importance of Metallo‐β‐Lactamase (MBL)–Producing StrainsThe Journal of Infectious Diseases, 2005
- Prevalence of metallo-β-lactamase among Pseudomonas aeruginosa and Acinetobacter baumannii in a Korean University hospital and comparison of screening methods for detecting metallo-β-lactamaseJournal of Microbiological Methods, 2003